Locations:
Search
Largest genomic assessment of MDS to date
Optimal sequencing of targeted therapies
Study’s findings are welcome news
Dedication to ongoing clinical care and research
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Phase 3 results reported in NEJM
Genetic analysis aids classification, therapeutic decisions
Simple protocol changes can shorten waits for care
Promising clinical trials underway
Molecular data enhance traditional scoring systems
Research improving myelodysplastic syndromes treatment
Advertisement
Advertisement